POLYMYXIN B (Xellia Pharmaceuticals ApS)


Welcome to the PulseAid listing for the POLYMYXIN B drug offered from Xellia Pharmaceuticals ApS. This Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Xellia Pharmaceuticals ApS
NON-PROPRIETARY NAME: POLYMYXIN B SULFATE
SUBSTANCE NAME: POLYMYXIN B SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-01-24
END MARKETING DATE: 0000-00-00


POLYMYXIN B HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPOLYMYXIN B from Xellia Pharmaceuticals ApS
LABELER NAME: Xellia Pharmaceuticals ApS
DEA SCHEDULE:
ACTIVE STRENGTH: 500000(1-Jan)
START MARKETING DATE: 2014-01-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 45932-0030_5039c2fa-cc43-4787-933c-a9943ca381eb
PRODUCT NDC: 45932-0030
APPLICATION NUMBER: ANDA202766

Other POLYMYXIN B SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Polymyxin B
Athenex Pharmaceutical Division, LLC.Polymyxin B
AuroMedics Pharma LLCPolymyxin B
Breckenridge Pharmaceutical, Inc.Polymyxin B
Fresenius Kabi USA, LLCPolymyxin B
Gland Pharma LimitedPOLYMYXIN B
X-GEN Pharmaceuticals, Inc.Polymyxin B
Xellia Pharmaceuticals ApSPOLYMYXIN B